CTOs on the Move

Balanced Health Botanicals

www.balancedhealthbotanicals.com

 
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Bayer Pharmaceutical Manufacturing Services

Bayer Pharmaceutical Manufacturing Services is a Shawnee, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ODONA/LTC

ODONA/LTC is a Shaker Hts, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DOCTORS HOSPITAL WEST COVINA

DOCTORS HOSPITAL WEST COVINA is a West Covina, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Samaritan Health Services

Samaritan Health Services is a non-profit network of hospitals,physician clinics and health services caring for the communities of the mid-Willamette Valley and central Oregon Coast. Our passion is providing world-class health care to our friends and neighbors. On the job and off, each of us brings the caring and personal commitment to enhance the health of the region we call home. We provide innovative medicine and world-class quality in a way that`s consistent with the values of the places we serve. That includes care and compassion for everyone, regardless of the ability to pay.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.